The clinical significance signal lymph node biopsy using indocyanine green after effective neoadjuvant chemotherapy with target therapy with early sporadic early HER2 positive breast cancer
According to the International Agency for Research on Cancer GLOBOCAN (Cancer Today), breast cancer ranks first in the structure of mortality from cancer among women. In recent decades, there has been a steady trend in the treatment of breast cancer to minimize the volume of radical surgical treatme...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Private institution educational organization of higher education "Medical University "ReaViz"
2025-04-01
|
| Series: | Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье |
| Subjects: | |
| Online Access: | https://vestnik.reaviz.ru/jour/article/view/1173 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850046461744513024 |
|---|---|
| author | K. S. Titov I. N. Kuts D. A. Karseladze I. N. Lebedinskiy Z. V. Lorie S. S. Lebedev D. N. Grekov |
| author_facet | K. S. Titov I. N. Kuts D. A. Karseladze I. N. Lebedinskiy Z. V. Lorie S. S. Lebedev D. N. Grekov |
| author_sort | K. S. Titov |
| collection | DOAJ |
| description | According to the International Agency for Research on Cancer GLOBOCAN (Cancer Today), breast cancer ranks first in the structure of mortality from cancer among women. In recent decades, there has been a steady trend in the treatment of breast cancer to minimize the volume of radical surgical treatment in order to improve the quality of patients lives and comply with the principles of oncological adequacy. A sentinel lymph node biopsy (SLNB) is an alternative to axillary lymphatic dissection in patients with clinically intact regional lymph nodes (cN0). This allows patients to avoid such formidable and often disabling complications of lymphatic dissection as – prolonged postoperative lymphorrhea and lymphatic swelling of the upper extremity (lymphostasis). Thanks to SLNB in combination with neoadjuvant therapy (NAT), which is most effective in HER2-positive tumors, the number of patients who underwent organ-preservation surgical treatment is steadily increasing. World trends go further and in the range of studies an attempt to abandon the implementation of SLNB has already been made in some groups of patients with early breast cancer. This article analyzes the experience and results of performing a fluorescent signal lymph node biopsy using indocyanine green after effective neoadjuvant polychemotherapy with target therapy in patients with early sporadic HER2-positive breast cancer in the oncology department of Botkin Hospital. |
| format | Article |
| id | doaj-art-33a9aab4f0ce4c8a8677d69d5886cc01 |
| institution | DOAJ |
| issn | 2226-762X 2782-1579 |
| language | Russian |
| publishDate | 2025-04-01 |
| publisher | Private institution educational organization of higher education "Medical University "ReaViz" |
| record_format | Article |
| series | Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье |
| spelling | doaj-art-33a9aab4f0ce4c8a8677d69d5886cc012025-08-20T02:54:27ZrusPrivate institution educational organization of higher education "Medical University "ReaViz"Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье2226-762X2782-15792025-04-01151616710.20340/vmi-rvz.2025.1.CLIN.5716The clinical significance signal lymph node biopsy using indocyanine green after effective neoadjuvant chemotherapy with target therapy with early sporadic early HER2 positive breast cancerK. S. Titov0I. N. Kuts1D. A. Karseladze2I. N. Lebedinskiy3Z. V. Lorie4S. S. Lebedev5D. N. Grekov6Moscow Multidisciplinary Scientific and Clinical Center named after S.P. Botkin; Peoples' Friendship University of Russia named after Patrice LumumbaPeoples' Friendship University of Russia named after Patrice LumumbaMoscow Multidisciplinary Scientific and Clinical Center named after S.P. BotkinMoscow Multidisciplinary Scientific and Clinical Center named after S.P. BotkinMoscow Multidisciplinary Scientific and Clinical Center named after S.P. BotkinMoscow Multidisciplinary Scientific and Clinical Center named after S.P. Botkin; Russian Medical Academy of Continuous Professional EducationMoscow Multidisciplinary Scientific and Clinical Center named after S.P. Botkin; Russian Medical Academy of Continuous Professional EducationAccording to the International Agency for Research on Cancer GLOBOCAN (Cancer Today), breast cancer ranks first in the structure of mortality from cancer among women. In recent decades, there has been a steady trend in the treatment of breast cancer to minimize the volume of radical surgical treatment in order to improve the quality of patients lives and comply with the principles of oncological adequacy. A sentinel lymph node biopsy (SLNB) is an alternative to axillary lymphatic dissection in patients with clinically intact regional lymph nodes (cN0). This allows patients to avoid such formidable and often disabling complications of lymphatic dissection as – prolonged postoperative lymphorrhea and lymphatic swelling of the upper extremity (lymphostasis). Thanks to SLNB in combination with neoadjuvant therapy (NAT), which is most effective in HER2-positive tumors, the number of patients who underwent organ-preservation surgical treatment is steadily increasing. World trends go further and in the range of studies an attempt to abandon the implementation of SLNB has already been made in some groups of patients with early breast cancer. This article analyzes the experience and results of performing a fluorescent signal lymph node biopsy using indocyanine green after effective neoadjuvant polychemotherapy with target therapy in patients with early sporadic HER2-positive breast cancer in the oncology department of Botkin Hospital.https://vestnik.reaviz.ru/jour/article/view/1173sentinel lymph node biopsy [d016207]breast neoplasms, her2-positive [d019275]indocyanine green [d000077598]neoadjuvant therapy [d009367]antineoplastic combined chemotherapy protocols [d000971]antineoplastic agents [d000970]targeted molecular therapy [d018417]molecular targeted therapy [d057285]early detection of cancer [d064042]erbb-2 receptor [d049109]lymphatic metastasis [d014057]disease-free survival [d018770] |
| spellingShingle | K. S. Titov I. N. Kuts D. A. Karseladze I. N. Lebedinskiy Z. V. Lorie S. S. Lebedev D. N. Grekov The clinical significance signal lymph node biopsy using indocyanine green after effective neoadjuvant chemotherapy with target therapy with early sporadic early HER2 positive breast cancer Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье sentinel lymph node biopsy [d016207] breast neoplasms, her2-positive [d019275] indocyanine green [d000077598] neoadjuvant therapy [d009367] antineoplastic combined chemotherapy protocols [d000971] antineoplastic agents [d000970] targeted molecular therapy [d018417] molecular targeted therapy [d057285] early detection of cancer [d064042] erbb-2 receptor [d049109] lymphatic metastasis [d014057] disease-free survival [d018770] |
| title | The clinical significance signal lymph node biopsy using indocyanine green after effective neoadjuvant chemotherapy with target therapy with early sporadic early HER2 positive breast cancer |
| title_full | The clinical significance signal lymph node biopsy using indocyanine green after effective neoadjuvant chemotherapy with target therapy with early sporadic early HER2 positive breast cancer |
| title_fullStr | The clinical significance signal lymph node biopsy using indocyanine green after effective neoadjuvant chemotherapy with target therapy with early sporadic early HER2 positive breast cancer |
| title_full_unstemmed | The clinical significance signal lymph node biopsy using indocyanine green after effective neoadjuvant chemotherapy with target therapy with early sporadic early HER2 positive breast cancer |
| title_short | The clinical significance signal lymph node biopsy using indocyanine green after effective neoadjuvant chemotherapy with target therapy with early sporadic early HER2 positive breast cancer |
| title_sort | clinical significance signal lymph node biopsy using indocyanine green after effective neoadjuvant chemotherapy with target therapy with early sporadic early her2 positive breast cancer |
| topic | sentinel lymph node biopsy [d016207] breast neoplasms, her2-positive [d019275] indocyanine green [d000077598] neoadjuvant therapy [d009367] antineoplastic combined chemotherapy protocols [d000971] antineoplastic agents [d000970] targeted molecular therapy [d018417] molecular targeted therapy [d057285] early detection of cancer [d064042] erbb-2 receptor [d049109] lymphatic metastasis [d014057] disease-free survival [d018770] |
| url | https://vestnik.reaviz.ru/jour/article/view/1173 |
| work_keys_str_mv | AT kstitov theclinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT inkuts theclinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT dakarseladze theclinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT inlebedinskiy theclinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT zvlorie theclinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT sslebedev theclinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT dngrekov theclinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT kstitov clinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT inkuts clinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT dakarseladze clinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT inlebedinskiy clinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT zvlorie clinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT sslebedev clinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer AT dngrekov clinicalsignificancesignallymphnodebiopsyusingindocyaninegreenaftereffectiveneoadjuvantchemotherapywithtargettherapywithearlysporadicearlyher2positivebreastcancer |